Is Single-incision Laparoscopic Cholecystectomy Feasible for Acute Cholecystitis? A Consecutive Study of 60 Cases

Abstract

The feasibility of single-incision laparoscopic cholecystectomy (SIL-C) for patients with acute cholecystitis were evaluated based on the timing of operation after onset of symptoms. Sixty patients with acute cholecystitis who underwent SIL-C were divided into 2 groups according to the timing of operation: group E included 23 patients who underwent SIL-C within 72 hours, and group O included 37 patients who underwent SIL-C later. There were no statistical differences between group E and group O in clinicopathologic characteristics. Group E demonstrated significantly shorter operating time and less blood loss than group O. Although the incidences of additional port(s) requirements were not significantly different, 8 patients in group O required open conversion, indicating significantly higher rate. As group E demonstrated favorable surgical outcomes compared with group O, SIL-C for acute cholecystitis seems to be a feasible therapeutic procedure when performed within 72 hours as updated Tokyo Guidelines recommended.

Optimal indication of single-incision laparoscopic cholecystectomy using Konyang Standard Method in benign gallbladder diseases

“…All of these factors may impede the safety of SILC. Several previous case-controlled studies on SILC in patients with AC reported a 3.6% to 18.3% rate of postoperative complications, 2.7% to 60.0% rate of additional port insertion, 0.4% to 18.3% rate of open conversion, and 5.7 to 9.4 days of postoperative hospital stay [ 3 , 4 , 18 , 19 ]. Despite a large number of patients with AC compared with previous studies, the surgical outcomes in the present study were relatively acceptable.…”

“…No significant sex differences were found between the two groups (p = 0.631). The PPO group included more patients aged ≥70 years (9.6% vs. 36.5%, p < 0.001) and patients with an ASA PS classification of ≥III (6.4% vs. 19.2%, p < 0.001) than the non-PPO group. The proportion of patients with AC was also higher in the PPO group than in the non-PPO group (29.4% vs. 55.8%, p < 0.001).…”